CStone Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- CStone Pharmaceuticals's estimated annual revenue is currently $53.3M per year.
- CStone Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- CStone Pharmaceuticals has 265 Employees.
- CStone Pharmaceuticals grew their employee count by -10% last year.
CStone Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is CStone Pharmaceuticals?
CStone Pharmaceuticals (HKEX:2616) is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, 5 late-stage candidates are at pivotal trials. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone's vision is to become globally recognized as a leading Chinese biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.
keywords:N/A
N/A
Total Funding
265
Number of Employees
$53.3M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CStone Pharmaceuticals News
SUZHOU, China, April 22, 2022 /PRNewswire/ -- The partner of CStone Pharmaceuticals ("CStone", HKEX: 2616), Servier, today announced the...
... drug company CStone Pharmaceuticals among firms that failed to file results by March 31 deadline; Exchange to keep period of any trading...
CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on research, development, and commercialization of innovative immuno-...
Other Companies in Shanghai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $44.8M | 281 | 5% | N/A |
#2 | $45.1M | 283 | -3% | N/A |
#3 | $80.9M | 308 | 9% | N/A |
#4 | $54.1M | 309 | 4% | N/A |
#5 | N/A | 318 | 3% | $500M |